Corona Remedies Pvt. Ltd. entered into an asset purchase agreement to acquire four drug brands from GlaxoSmithkline Pharmaceuticals Limited (BSE:500660) on March 7, 2017. As per the agreement, Dilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill. The transaction is approved by the Competition Commission of India.